Skin conditions (dermatitis, eczema, psoriasis) Board decisions

The Veteran withdrew the appeals for service connection and initial rating, resulting in their dismissal.

The Board granted service connection for otitis media of the right ear with conductive hearing loss and denied increased ratings for tinnitus and eczema.

The Board granted a 10 percent rating for chronic sinusitis and denied service connection for eczema.

The Board denied service connection for acne, a bladder disorder, and a headache disorder as they are not shown to be causally or etiologically related to any disease, injury, or incident during the Veteran's military service.

The Board denied higher ratings for PTSD and alcohol and cannabis use disorder but granted a 10% rating for seborrheic dermatitis from August 9, 2018 to May 25, 2021.

The Board granted service connection for chloracne, finding that the Veteran's exposure to herbicide agents during his military service in Vietnam caused the condition.

The Board denied the veteran's claims for an initial compensable disability rating for dermatitis and service connection for posttraumatic stress disorder, anxiety condition, and obstructive sleep apnea.

The Board granted service connection for pseudofolliculitis barbae and remanded several other claims, including diabetes, urinary disorder, bilateral hearing loss, back disability, traumatic brain injury (TBI), neurological disorder, left shoulder disability, neck disability, and tinnitus.

The Board granted service connection for trochanteric pain syndrome of bilateral hips, bilateral ankle sprain, and patellofemoral pain syndrome of bilateral knees. The remaining claims were denied.

The Veteran was granted an initial rating of 20 percent for neoplasm of the kidney, but no higher. The claim for a higher initial rating for eczema was denied.

The Board denied an effective date prior to January 24, 2023, for the award of service connection for tinea versicolor.

The Board granted service connection for hypertension and cardiomyopathy as secondary to the Veteran's service-connected lumbar spine and radiculopathy disabilities, with obesity as an intermediate step. The claims for left knee disability, right knee disability, left ankle condition, and eczema were remanded.

The Board remands the claims for service connection for prostate cancer with perineural invasion and skin condition, to include dermatitis, due to inadequate medical opinions.

The Board denied increased ratings for PTSD, left shoulder rotator cuff tear, and dermatitis while granting a 20% rating for the left ankle disability and a 10% rating for the right great toe scar. The Veteran's eligibility for Dependents' Educational Assistance was also denied.

The Board granted a higher initial 30 percent rating for allergic rhinosinusitis and denied or remanded the other issues.

The Board granted a 30 percent rating for bilateral tinea pedis, resolving reasonable doubt in the Veteran's favor.

The Board remands the claim for an additional examination to better reflect the predominant severity of the Veteran's skin condition and to determine if oral medication is considered systemic therapy.

The Board denied the Veteran's appeal for an increased rating in excess of 10 percent for psoriasis, as the evidence did not support a higher rating under the applicable criteria.

The Board granted service connection for hypertension, PTSD, and peripheral neuropathy of the upper and lower extremities effective March 29, 2022. The claim for a back condition was remanded for further development.

The Board granted service connection for anxiety disorder, acne, heart palpitations/mitral valve prolapse, irritable bowel syndrome and esophagitis, left lower extremity radiculopathy, and right lower extremity radiculopathy, effective April 1, 2017. It denied an earlier effective date for migraines, pes planus, plantar fasciitis, and hallux valgus.